These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 29307777)
21. Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors. Fujimoto M; Ohte S; Osawa K; Miyamoto A; Tsukamoto S; Mizuta T; Kokabu S; Suda N; Katagiri T Mol Endocrinol; 2015 Jan; 29(1):140-52. PubMed ID: 25354296 [TBL] [Abstract][Full Text] [Related]
22. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call. Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268 [TBL] [Abstract][Full Text] [Related]
23. Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis. Stanley A; Heo SJ; Mauck RL; Mourkioti F; Shore EM J Bone Miner Res; 2019 Oct; 34(10):1894-1909. PubMed ID: 31107558 [TBL] [Abstract][Full Text] [Related]
24. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva. Katagiri T; Tsukamoto S; Kuratani M Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575 [TBL] [Abstract][Full Text] [Related]
25. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Shore EM Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058 [TBL] [Abstract][Full Text] [Related]
26. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447 [TBL] [Abstract][Full Text] [Related]
27. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436 [TBL] [Abstract][Full Text] [Related]
28. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044 [TBL] [Abstract][Full Text] [Related]
29. Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva. Maruyama R; Yokota T Methods Mol Biol; 2018; 1828():497-502. PubMed ID: 30171563 [TBL] [Abstract][Full Text] [Related]
30. Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva. Luo Y; Alsamarah A; Zhang K; Hao J Curr Mol Med; 2016; 16(1):4-11. PubMed ID: 26695699 [TBL] [Abstract][Full Text] [Related]
32. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene. Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384 [TBL] [Abstract][Full Text] [Related]